公司的收入超过预期,增加了营收,并宣布股息, 而董事卖掉了股票. Stryker Corp. beat earnings estimates, raised revenue, and declared a dividend, while a director sold shares.

斯特莱克公司报告第四季度每股收益为4.47美元,超过预期的0.07美元,收入71.7亿美元,同比增长11.4%. Stryker Corporation reported fourth-quarter earnings of $4.47 per share, beating estimates by $0.07, and revenue of $7.17 billion, up 11.4% year-over-year. 医疗技术公司宣布季度股息为0.88美元, 4月30日付款,收益率为1.0%. The medical technology company declared a quarterly dividend of $0.88, payable April 30, yielding 1.0%. 分析师保持"中等购买"评级,目标价为427.50美元. Analysts maintain a "Moderate Buy" rating with a $427.50 target price. 一位公司董事以362.92美元的价格出售了25万股, 减少了他们持有的9.23%. A company director sold 250,000 shares at $362.92, reducing their stake by 9.23%. 在2026年3月20日,该股票收盘时价格为339.97美元,52周的波动范围是328.23至404.87美元. The stock closed at $339.97 on March 20, 2026, with a 52-week range of $328.23 to $404.87.